159 related articles for article (PubMed ID: 11911309)
1. In vitro chemosensitivity of human soft tissue sarcoma.
Morioka H; Yabe H; Morii T; Yamada R; Kato S; Yuasa S; Yano T
Anticancer Res; 2001; 21(6A):4147-51. PubMed ID: 11911309
[TBL] [Abstract][Full Text] [Related]
2. In vitro characterisation of soft tissue tumor chemosensitivity.
Remmelink M; Salmon I; Delville JP; Goldschmidt D; Capel P; Gebhart M; Pasteels JL; Kiss R; Darro F
Anticancer Res; 1997; 17(3C):2009-17. PubMed ID: 9216658
[TBL] [Abstract][Full Text] [Related]
3. The pharmacologic basis of ifosfamide use in adult patients with advanced soft tissue sarcomas.
Tascilar M; Loos WJ; Seynaeve C; Verweij J; Sleijfer S
Oncologist; 2007 Nov; 12(11):1351-60. PubMed ID: 18055856
[TBL] [Abstract][Full Text] [Related]
4. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
[TBL] [Abstract][Full Text] [Related]
5. [Indication of chemotherapy according to histological type of musculoskeletal sarcomas].
Goto T; Okuma T; Ogura K; Imanishi J; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2009 Feb; 36(2):199-203. PubMed ID: 19223736
[TBL] [Abstract][Full Text] [Related]
6. Concomitant chemo-radiotherapy in the treatment of locally advanced and/or metastatic soft tissue sarcomas: experience of the National Cancer Institute of Genoa.
Toma S; Canavese G; Grimaldi A; Ravera G; Ugolini D; Percivale P; Badellino F
Oncol Rep; 2003; 10(3):641-7. PubMed ID: 12684637
[TBL] [Abstract][Full Text] [Related]
7. Preliminary study of chemosenstivity tests in osteosarcoma using a histoculture drug response assay.
Lee SY; Jeon DG; Cho WH; Song WS; Kim MB; Park JH
Anticancer Res; 2006; 26(4B):2929-32. PubMed ID: 16886615
[TBL] [Abstract][Full Text] [Related]
8. [The clinical correlation of human tumor clonogenic assay for malignant bone and soft tissue sarcoma of the extremities].
Tomita K; Yokogawa A; Shimozaki E
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1214-20. PubMed ID: 3729444
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of chemotherapy based on an in vitro chemosensitivity test in urothelial cancer patients.
Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
Anticancer Res; 2001; 21(6A):4061-6. PubMed ID: 11911292
[TBL] [Abstract][Full Text] [Related]
10. In vitro antitumor activity of 4'-O-tetrahydropyranyladriamycin on human gastric cancer cells.
Yamaue H; Tanimura H; Noguchi K; Shono Y; Iwahashi M; Hotta T; Tani M; Tsunoda T; Nishimoto N; Terasawa H; Nakamori M
Anticancer Res; 1996; 16(1):243-6. PubMed ID: 8615614
[TBL] [Abstract][Full Text] [Related]
11. [Soft tissue sarcoma: postoperative chemotherapy].
Goto T; Kosaku H; Kobayashi H; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1324-30. PubMed ID: 15446551
[TBL] [Abstract][Full Text] [Related]
12. Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy.
King JJ; Fayssoux RS; Lackman RD; Ogilvie CM
Am J Clin Oncol; 2009 Jun; 32(3):308-13. PubMed ID: 19433963
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy in soft tissue sarcomas].
Zelek L
Cancer Radiother; 2006; 10(1-2):68-71. PubMed ID: 16380283
[TBL] [Abstract][Full Text] [Related]
14. [Experience and discussion on treatment of high-grade soft tissue sarcomas of crura in youth].
Zong XY; Shi YQ
Zhonghua Wai Ke Za Zhi; 2004 Oct; 42(20):1247-9. PubMed ID: 15598374
[TBL] [Abstract][Full Text] [Related]
15. [Chemosensitivity testing by regrowth assay against malignant bone and soft tissue tumors].
Sato H
Nihon Seikeigeka Gakkai Zasshi; 1991 Apr; 65(4):181-95. PubMed ID: 2056234
[TBL] [Abstract][Full Text] [Related]
16. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE
Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822
[TBL] [Abstract][Full Text] [Related]
17. New emerging drugs in soft tissue sarcoma.
Milano A; Apice G; Ferrari E; Fazioli F; de Rosa V; de Luna AS; Iaffaioli RV; Caponigro F
Crit Rev Oncol Hematol; 2006 Jul; 59(1):74-84. PubMed ID: 16533604
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.
Maurel J; López-Pousa A; de Las Peñas R; Fra J; Martín J; Cruz J; Casado A; Poveda A; Martínez-Trufero J; Balañá C; Gómez MA; Cubedo R; Gallego O; Rubio-Viqueira B; Rubió J; Andrés R; Sevilla I; de la Cruz JJ; Del Muro XG; Buesa JM
J Clin Oncol; 2009 Apr; 27(11):1893-8. PubMed ID: 19273704
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines.
Hartmann JT
Anticancer Drugs; 2007 Mar; 18(3):245-54. PubMed ID: 17264755
[TBL] [Abstract][Full Text] [Related]
20. Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Leahy M; Ray-Coquard I; Verweij J; Le Cesne A; Duffaud F; Hogendoorn PC; Fowst C; de Balincourt C; di Paola ED; van Glabbeke M; Judson I; Blay JY;
Eur J Cancer; 2007 Jan; 43(2):308-15. PubMed ID: 17095209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
